citalopram has been researched along with carbamazepine in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (5.71) | 18.2507 |
2000's | 14 (40.00) | 29.6817 |
2010's | 16 (45.71) | 24.3611 |
2020's | 3 (8.57) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Sen, S; Sinha, N | 1 |
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
Doran, AC; Mancuso, JY; Osgood, SM; Shaffer, CL | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Koponen, H; Leinonen, E; Lepola, U | 1 |
Dailey, JW; Jobe, PC; Milbrandt, JC; Reith, ME; Steidley, KR | 1 |
Cicolini, A; Monaco, F; Perino, C; Rago, R; Torta, R | 1 |
Khant, AZ; Larsen, F; Møller, SE; Rolan, PE | 1 |
Baumann, P; Brawand-Amey, M; Eap, CB; Steinacher, L; Vandel, P; Zullino, DF | 1 |
Erdogan, A; Ozkara, C; Ozmen, M; Yalug, I | 1 |
Deb, S; Unwin, GL | 1 |
Kessler, H; Kraft, S | 1 |
Aggarwal, A; Garg, A; Jain, M; Jiloha, RC | 1 |
Brozinski, JM; Kronberg, L; Lahti, M; Oikari, A; Segner, H | 1 |
Holsboer, F; Perisic, T; Rein, T; Yu, S; Zimmermann, N; Zschocke, J | 1 |
Gaytán-Martínez, LA; Pérez-Gómez, HR; Ramos-Zúñiga, R; Rochín-Mozqueda, A; Soto-Rodríguez, S; Vega-Ruiz, B | 1 |
Aouinti, I; Charfi, O; Daghfous, R; El Aidli, S; Kastalli, S; Lakhoua, G; Zaiem, A | 1 |
Fér, M; Grabic, R; Grabicová, K; Klement, A; Kočárek, M; Kodešová, R; Nikodem, A; Schmidtová, Z; Švecová, H | 1 |
Beretsou, VG; Fatta-Kassinos, D; Lundy, L; Manoli, K; Michael, C; Nika, MC; Revitt, DM; Sui, Q; Thomaidis, NS | 1 |
Chroňáková, A; Fedorova, G; Fér, M; Grabic, R; Klement, A; Kočárek, M; Kodešová, R; Nikodem, A; Rieznyk, O; Sadchenko, A; Švecová, H | 1 |
2 review(s) available for citalopram and carbamazepine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Neuropsychiatric symptoms in Sotos syndrome. Case report and review of the literature].
Topics: Adult; Antipsychotic Agents; Brain; Carbamazepine; Chromosome Deletion; Citalopram; Compulsive Behavior; Craniofacial Abnormalities; Drug Therapy, Combination; Facies; Female; Gigantism; Hallucinations; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Intracellular Signaling Peptides and Proteins; Learning Disabilities; Neurocognitive Disorders; Neuropsychological Tests; Nuclear Proteins; Risperidone; Selective Serotonin Reuptake Inhibitors; Syndrome | 2008 |
1 trial(s) available for citalopram and carbamazepine
Article | Year |
---|---|
Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects.
Topics: Adolescent; Adult; Analysis of Variance; Anticonvulsants; Area Under Curve; Carbamazepine; Chromatography, High Pressure Liquid; Citalopram; Drug Interactions; Humans; Male; Maximum Tolerated Dose; Middle Aged; Polypharmacy; Reference Values; Selective Serotonin Reuptake Inhibitors | 2001 |
32 other study(ies) available for citalopram and carbamazepine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Brain Chemistry; Dogs; Isoxazoles; Male; Paliperidone Palmitate; Primates; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Thiophenes | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Carbamazepine; Citalopram; Depressive Disorder; Drug Interactions; Epilepsy; Female; Humans; Male; Oxcarbazepine; Panic Disorder | 1996 |
Carbamazepine-induced release of serotonin from rat hippocampus in vitro.
Topics: Animals; Anticonvulsants; Carbamazepine; Carrier Proteins; Citalopram; Fluoxetine; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Synaptosomes | 1998 |
Mood and behavioural disorders following traumatic brain injury: clinical evaluation and pharmacological management.
Topics: Adult; Antidepressive Agents; Brain Injuries; Brief Psychiatric Rating Scale; Carbamazepine; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Glasgow Coma Scale; Humans; Male; Mental Disorders | 2001 |
Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antimanic Agents; Carbamazepine; Citalopram; Depressive Disorder, Major; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Statistics, Nonparametric; Stereoisomerism | 2002 |
Topiramate related obsessive-compulsive disorder.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Carbamazepine; Citalopram; Dose-Response Relationship, Drug; Epilepsies, Partial; Fructose; Humans; Lamotrigine; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Topiramate; Triazines | 2005 |
Use of medication for the management of behavior problems among adults with intellectual disabilities: a clinicians' consensus survey.
Topics: Adult; Aggression; Antipsychotic Agents; Attitude of Health Personnel; Autistic Disorder; Carbamazepine; Child; Citalopram; Consensus; Humans; Mental Disorders; Risperidone; Self-Injurious Behavior; Surveys and Questionnaires | 2008 |
Carbamazepine for serotonin reuptake inhibitor nonresponder case of obsessive compulsive disorder.
Topics: Adult; Anticonvulsants; Carbamazepine; Citalopram; Depressive Disorder, Major; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Failure | 2009 |
Bioavailability of pharmaceuticals in waters close to wastewater treatment plants: use of fish bile for exposure assessment.
Topics: Animals; Anti-Inflammatory Agents; Bile; Biological Availability; Carbamazepine; Chromatography, Liquid; Citalopram; Cyclohexanols; Diclofenac; Finland; Ibuprofen; Liver; Male; Naproxen; Oncorhynchus mykiss; Plasma; Venlafaxine Hydrochloride; Wastewater; Water Pollutants, Chemical | 2012 |
Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels.
Topics: Animals; Antidepressive Agents; Astrocytes; Carbamazepine; Cells, Cultured; Cerebral Cortex; Citalopram; Cyclohexanols; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Glycolipids; Histone-Lysine N-Methyltransferase; Imipramine; Indoles; Maleimides; Mice; Nerve Tissue Proteins; Neural Stem Cells; Neurons; Paroxetine; Protein Interaction Mapping; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Venlafaxine Hydrochloride | 2012 |
[Temporal lobe epilepsy and active neurocysticercosis: two representative case reports].
Topics: Albendazole; Anomia; Anthelmintics; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Citalopram; Delayed Diagnosis; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Headache; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurocysticercosis; Oxcarbazepine; Panic Disorder; Perphenazine; Prednisone | 2015 |
Recurrence of DRESS syndrome to escitalopram or neosensitization?
Topics: Adult; Antidepressive Agents; Carbamazepine; Citalopram; Drug Hypersensitivity Syndrome; Female; Humans; Recurrence; Tunisia | 2019 |
Competitive and synergic sorption of carbamazepine, citalopram, clindamycin, fexofenadine, irbesartan and sulfamethoxazole in seven soils.
Topics: Adsorption; Carbamazepine; Citalopram; Clindamycin; Irbesartan; Soil; Soil Pollutants; Sulfamethoxazole; Terfenadine | 2020 |
Multiclass target analysis of contaminants of emerging concern including transformation products, soil bioavailability assessment and retrospective screening as tools to evaluate risks associated with reclaimed water reuse.
Topics: Biological Availability; Carbamazepine; Citalopram; Illicit Drugs; Lamotrigine; Retrospective Studies; Soil; Sweetening Agents; Tramadol; Venlafaxine Hydrochloride; Wastewater; Water; Water Pollutants, Chemical | 2022 |
Contamination of water, soil, and plants by micropollutants from reclaimed wastewater and sludge from a wastewater treatment plant.
Topics: Carbamazepine; Citalopram; Gabapentin; Humans; Sertraline; Sewage; Soil; Soil Pollutants; Telmisartan; Tramadol; Vegetables; Venlafaxine Hydrochloride; Wastewater; Water | 2024 |